Cited by

• Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.

  Pelizzo G, Veschi V, Mantelli M, Croce S, Di Benedetto V, D'Angelo P, Maltese A, Catenacci L, Apuzzo T, Scavo E, Moretta A, Todaro M, Stassi G, Avanzini MA, Calcaterra V. Pelizzo G, et al. BMC Cancer. 2018 Nov 27;18(1):1176. doi: 10.1186/s12885-018-5082-2. BMC Cancer. 2018. PMID: 30482160 Free PMC article.
• Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment.

  Veschi V, Turdo A, Stassi G. Veschi V, et al. Front Mol Med. 2023 May 18;3:1120090. doi: 10.3389/fmmed.2023.1120090. eCollection 2023. Front Mol Med. 2023. PMID: 39086678 Free PMC article.
• Bioinformatics Analysis of Neuroblastoma miRNA Based on GEO Data.

  Shi J, Zhang P, Su H, Cai L, Zhao L, Zhou H. Shi J, et al. Pharmgenomics Pers Med. 2021 Jul 13;14:849-858. doi: 10.2147/PGPM.S312171. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34285553 Free PMC article.
• Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

  Tucker ER, Jiménez I, Chen L, Bellini A, Gorrini C, Calton E, Gao Q, Che H, Poon E, Jamin Y, Martins Da Costa B, Barker K, Shrestha S, Hutchinson JC, Dhariwal S, Goodman A, Del Nery E, Gestraud P, Bhalshankar J, Iddir Y, Saberi-Ansari E, Saint-Charles A, Geoerger B, Marques Da Costa ME, Pierre-Eugène C, Janoueix-Lerosey I, Decaudin D, Nemati F, Carcaboso AM, Surdez D, Delattre O, George SL, Chesler L, Tweddle DA, Schleiermacher G. Tucker ER, et al. Clin Cancer Res. 2023 Apr 3;29(7):1317-1331. doi: 10.1158/1078-0432.CCR-22-2274. Clin Cancer Res. 2023. PMID: 36602782 Free PMC article.
• Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges.

  Chen Y, Liu X, Li Y, Quan C, Zheng L, Huang K. Chen Y, et al. Comput Struct Biotechnol J. 2018 Jun 20;16:211-223. doi: 10.1016/j.csbj.2018.06.001. eCollection 2018. Comput Struct Biotechnol J. 2018. PMID: 30002791 Free PMC article. Review.